Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 5,320.00
+250.00 (4.93%)
At close: Jul 10, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 68.87 billion as of July 10, 2026. Its market cap has decreased by -19.64% in one year.
Market Cap
68.87B
Enterprise Value
53.54B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,320.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 68.87B, a decrease of -38.93%. That is a compound annual growth rate of -15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 68.87B | -43.34% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 90.60B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 87.12B |
| KOREA PHARMA | 84.85B |
| Daehan Nupharm | 80.42B |
| Sam-A Pharm. | 78.24B |
| Polaris AI Pharma | 76.38B |
| Hwail Pharmaceutical | 71.89B |
| Optipharm.CO.,LTD | 69.02B |